title: Clinical experience with a lipid-free, ready-made parenteral nutrition solution in dogs: 70 cases (2006-2012).
abstract: OBJECTIVE
  To review the clinical use of a lipid-free, ready-made amino acid and glucose parenteral nutrition (PN) solution in dogs.
  
  
  METHODS
  Retrospective study of dogs from 2006 to 2012 that received this form of PN.
  
  
  METHODS
  University veterinary teaching hospital.
  
  
  METHODS
  Seventy dogs presented to the hospital for treatment of various diseases in which PN was used as part of patient management. Dogs were administered PN at the discretion of the primary clinician.
  
  
  METHODS
  A lipid-free, ready-made solution containing amino acid (59 g/L) and dextrose (100 g/L) was administered intravenously as a constant rate infusion to provide nutritional support.
  
  
  RESULTS
  PN was provided for a median of 2.2 days (range 0.5-9.5 days) in the 70 dogs, totaling 168 days of PN. The PN provided a median of 5.5 g/100 kcal of protein (range 1-9.5 g/100 kcal) and a median of 2.2 mg/kg of bodyweight per minute (range 0.8-5.2 mg/kg/min) of glucose, which reflected a median of 57% of the resting energy requirement (range 9-100%). Metabolic complications developed in 43 of 67 dogs where these data were recorded, but the development of hyperkalemia was the only complication associated with a poor outcome (eg, death or euthanasia). Mechanical complications were seen in 28 dogs, and all but one of these occurred when PN was delivered through peripheral catheters. Septic complications were confirmed in 5 dogs.
  
  
  CONCLUSIONS
  This form of PN is suitable for clinical use and can provide both protein and calories to ill dogs. It was, however, associated with a high rate of complications and requires careful patient monitoring.
authors: Departments of Veterinary Clinical Sciences, The Royal Veterinary College, Hatfield, United Kingdom.
authors: Isuru
authors: I
authors: Gajanayake
authors: Claire E
authors: CE
authors: Wylie
authors: Daniel L
authors: DL
authors: Chan
mesh_terms: D000818:Animals; D000855:Anorexia / Q000628:therapy / Q000662:veterinary; D003680:Deglutition Disorders / Q000628:therapy / Q000662:veterinary; D004283:Dog Diseases / Q000628:therapy*; D004285:Dogs; D004734:Energy Metabolism; D005260:Female; D005947:Glucose / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D010288:Parenteral Nutrition / Q000662:veterinary*; D057947:Parenteral Nutrition Solutions / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D012121:Respiration, Artificial / Q000662:veterinary; D012189:Retrospective Studies; D016896:Treatment Outcome; D014313:Trismus / Q000628:therapy / Q000662:veterinary; D014839:Vomiting / Q000628:therapy / Q000662:veterinary
chemical_list: D057947:Parenteral Nutrition Solutions; D005947:Glucose